Danish firm behind weight-loss drug Wegovy raises profit forecast to £15.3bn
1 Mins read
Reading Time: < 1 minute Strong sales of diabetes and weight loss drugs Ozempic and Wegovy have prompted the Danish pharmaceutical company Novo Nordisk to raise its…